NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 219 filers reported holding NPS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $312,615,000 | +40.9% | 8,739,584 | +2.4% | 0.08% | +36.1% |
| Q3 2014 | $221,827,000 | -20.9% | 8,531,800 | +0.5% | 0.06% | -18.7% |
| Q2 2014 | $280,469,000 | +14.6% | 8,486,193 | +3.7% | 0.08% | +10.3% |
| Q1 2014 | $244,812,000 | +23.0% | 8,179,532 | +24.8% | 0.07% | +19.3% |
| Q4 2013 | $198,977,000 | +14.4% | 6,553,966 | +19.8% | 0.06% | +5.6% |
| Q3 2013 | $173,998,000 | +51.4% | 5,469,898 | -28.1% | 0.05% | +42.1% |
| Q2 2013 | $114,944,000 | – | 7,612,155 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 424,175 | $12,695,000 | 5.06% |
| Opaleye Management Inc. | 150,000 | $4,490,000 | 3.32% |
| OAK RIDGE INVESTMENTS LLC | 2,795,331 | $83,664,000 | 2.10% |
| SCHOLTZ & COMPANY, LLC | 60,350 | $1,806,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,408,729 | $42,163,000 | 1.73% |
| First Light Asset Management, LLC | 79,099 | $2,367,000 | 1.68% |
| FCG ADVISORS, LLC | 71,146 | $2,129,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 166,970 | $4,997,000 | 1.50% |
| BENDER ROBERT & ASSOCIATES | 73,611 | $2,203,000 | 1.48% |
| Eventide Asset Management | 283,900 | $8,497,000 | 1.32% |